Role of endogenous opioid peptides in protection of ischemic preconditioning in rat small intestine

Life Sci. 2001 Jan 19;68(9):1013-9. doi: 10.1016/s0024-3205(00)01004-3.

Abstract

This study investigated the protective effects of ischemic preconditioning on intestinal ischemic injury and the role of endogenous opioid peptides (EOP) in these effects. Ischemia-reperfusion (I/R) induced by 30-min of ischemia and 60-min of reperfusion significantly increased the levels of malondialdehyde (MDA) and lactate dehydrogenase (LDH) and resulted in serious intestinal edema (wet weight/dry weight). The ischemic preconditioning (PC) elicited by three 8-min occlusion periods interspersed with 10-min reperfusion markedly attenuated intestinal injury caused by ischemia-reperfusion. Pretreatment with morphine (300 microg x kg(-1), i.v.) 10-min before ischemia and reperfusion mimicked the protection produced by PC. Naloxone (3 mg x kg(-1), i.v.) abolished the protection of morphine-induced preconditioning and ischemic preconditioning in rat intestine. However, there were no changes between naloxone alone and control groups. Treatment with naloxone before ischemia-reperfusion had no effect on animals compared with the I/R group. In addition, we also measured the content of endogenous opioid peptides (Leu-enkephalin) in the effluent which was collected before and during preconditioning. It was shown that the release of leu-enkephalin was markedly increased during preconditioning. These results suggested that EOP might play an important role in PC in rat small intestine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / antagonists & inhibitors
  • Analgesics, Opioid / pharmacology
  • Animals
  • Drug Interactions
  • Edema / etiology
  • Edema / prevention & control
  • Enkephalin, Leucine / metabolism
  • Intestinal Diseases / etiology
  • Intestinal Diseases / metabolism
  • Intestinal Diseases / prevention & control
  • Intestinal Mucosa / pathology
  • Intestine, Small / blood supply*
  • Intestine, Small / pathology
  • Intestine, Small / physiology
  • Ischemia / metabolism
  • Ischemic Preconditioning*
  • L-Lactate Dehydrogenase / metabolism
  • Male
  • Malondialdehyde / metabolism
  • Morphine / antagonists & inhibitors
  • Morphine / pharmacology
  • Naloxone / pharmacology
  • Narcotic Antagonists / pharmacology
  • Opioid Peptides / metabolism
  • Opioid Peptides / physiology*
  • Rats
  • Rats, Wistar
  • Receptors, Opioid / physiology
  • Reperfusion Injury / metabolism
  • Reperfusion Injury / prevention & control

Substances

  • Analgesics, Opioid
  • Narcotic Antagonists
  • Opioid Peptides
  • Receptors, Opioid
  • Naloxone
  • Malondialdehyde
  • Enkephalin, Leucine
  • Morphine
  • L-Lactate Dehydrogenase